Global Vaginal Antifungal Supply, Demand and Key Producers, 2023-2029
The global Vaginal Antifungal market size is expected to reach $ million by 2029, rising at a market growth of % CAGR during the forecast period (2023-2029).
This report studies the global Vaginal Antifungal demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaginal Antifungal, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaginal Antifungal that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaginal Antifungal total market, 2018-2029, (USD Million)
Global Vaginal Antifungal total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Vaginal Antifungal total market, key domestic companies and share, (USD Million)
Global Vaginal Antifungal revenue by player and market share 2018-2023, (USD Million)
Global Vaginal Antifungal total market by Type, CAGR, 2018-2029, (USD Million)
Global Vaginal Antifungal total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Vaginal Antifungal market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ANI Pharmaceuticals, Lupin, Unique Pharmaceuticals, Pfizer, SCYNEXIS, Bausch Health Companies, Hikma Pharmaceuticals, Pacgen Life Science Corporation and Astellas Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaginal Antifungal market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vaginal Antifungal Market, By Region:
1. How big is the global Vaginal Antifungal market?
2. What is the demand of the global Vaginal Antifungal market?
3. What is the year over year growth of the global Vaginal Antifungal market?
4. What is the total value of the global Vaginal Antifungal market?
5. Who are the major players in the global Vaginal Antifungal market?
6. What are the growth factors driving the market demand?
This report studies the global Vaginal Antifungal demand, key companies, and key regions.
This report is a detailed and comprehensive analysis of the world market for Vaginal Antifungal, and provides market size (US$ million) and Year-over-Year (YoY) growth, considering 2022 as the base year. This report explores demand trends and competition, as well as details the characteristics of Vaginal Antifungal that contribute to its increasing demand across many markets.
Highlights and key features of the study
Global Vaginal Antifungal total market, 2018-2029, (USD Million)
Global Vaginal Antifungal total market by region & country, CAGR, 2018-2029, (USD Million)
U.S. VS China: Vaginal Antifungal total market, key domestic companies and share, (USD Million)
Global Vaginal Antifungal revenue by player and market share 2018-2023, (USD Million)
Global Vaginal Antifungal total market by Type, CAGR, 2018-2029, (USD Million)
Global Vaginal Antifungal total market by Application, CAGR, 2018-2029, (USD Million)
This reports profiles major players in the global Vaginal Antifungal market based on the following parameters – company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include ANI Pharmaceuticals, Lupin, Unique Pharmaceuticals, Pfizer, SCYNEXIS, Bausch Health Companies, Hikma Pharmaceuticals, Pacgen Life Science Corporation and Astellas Pharma, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Vaginal Antifungal market
Detailed Segmentation:
Each section contains quantitative market data including market by value (US$ Millions), by player, by regions, by Type, and by Application. Data is given for the years 2018-2029 by year with 2022 as the base year, 2023 as the estimate year, and 2024-2029 as the forecast year.
Global Vaginal Antifungal Market, By Region:
- United States
- China
- Europe
- Japan
- South Korea
- ASEAN
- India
- Rest of World
- Fluconazole
- Clotrimazole
- Ketoconazole
- Others
- Hospital
- Clinic
- Pharmacy
- ANI Pharmaceuticals
- Lupin
- Unique Pharmaceuticals
- Pfizer
- SCYNEXIS
- Bausch Health Companies
- Hikma Pharmaceuticals
- Pacgen Life Science Corporation
- Astellas Pharma
- Mycovia Pharmaceuticals
- PEPTONIC Medical
1. How big is the global Vaginal Antifungal market?
2. What is the demand of the global Vaginal Antifungal market?
3. What is the year over year growth of the global Vaginal Antifungal market?
4. What is the total value of the global Vaginal Antifungal market?
5. Who are the major players in the global Vaginal Antifungal market?
6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY
1.1 Vaginal Antifungal Introduction
1.2 World Vaginal Antifungal Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Vaginal Antifungal Total Market by Region (by Headquarter Location)
1.3.1 World Vaginal Antifungal Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Vaginal Antifungal Market Size (2018-2029)
1.3.3 China Vaginal Antifungal Market Size (2018-2029)
1.3.4 Europe Vaginal Antifungal Market Size (2018-2029)
1.3.5 Japan Vaginal Antifungal Market Size (2018-2029)
1.3.6 South Korea Vaginal Antifungal Market Size (2018-2029)
1.3.7 ASEAN Vaginal Antifungal Market Size (2018-2029)
1.3.8 India Vaginal Antifungal Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaginal Antifungal Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaginal Antifungal Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vaginal Antifungal Consumption Value (2018-2029)
2.2 World Vaginal Antifungal Consumption Value by Region
2.2.1 World Vaginal Antifungal Consumption Value by Region (2018-2023)
2.2.2 World Vaginal Antifungal Consumption Value Forecast by Region (2024-2029)
2.3 United States Vaginal Antifungal Consumption Value (2018-2029)
2.4 China Vaginal Antifungal Consumption Value (2018-2029)
2.5 Europe Vaginal Antifungal Consumption Value (2018-2029)
2.6 Japan Vaginal Antifungal Consumption Value (2018-2029)
2.7 South Korea Vaginal Antifungal Consumption Value (2018-2029)
2.8 ASEAN Vaginal Antifungal Consumption Value (2018-2029)
2.9 India Vaginal Antifungal Consumption Value (2018-2029)
3 WORLD VAGINAL ANTIFUNGAL COMPANIES COMPETITIVE ANALYSIS
3.1 World Vaginal Antifungal Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Vaginal Antifungal Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Vaginal Antifungal in 2022
3.2.3 Global Concentration Ratios (CR8) for Vaginal Antifungal in 2022
3.3 Vaginal Antifungal Company Evaluation Quadrant
3.4 Vaginal Antifungal Market: Overall Company Footprint Analysis
3.4.1 Vaginal Antifungal Market: Region Footprint
3.4.2 Vaginal Antifungal Market: Company Product Type Footprint
3.4.3 Vaginal Antifungal Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Vaginal Antifungal Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Vaginal Antifungal Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Vaginal Antifungal Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Vaginal Antifungal Consumption Value Comparison
4.2.1 United States VS China: Vaginal Antifungal Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vaginal Antifungal Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Vaginal Antifungal Companies and Market Share, 2018-2023
4.3.1 United States Based Vaginal Antifungal Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Vaginal Antifungal Revenue, (2018-2023)
4.4 China Based Companies Vaginal Antifungal Revenue and Market Share, 2018-2023
4.4.1 China Based Vaginal Antifungal Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Vaginal Antifungal Revenue, (2018-2023)
4.5 Rest of World Based Vaginal Antifungal Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Vaginal Antifungal Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Vaginal Antifungal Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaginal Antifungal Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Fluconazole
5.2.2 Clotrimazole
5.2.3 Ketoconazole
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Vaginal Antifungal Market Size by Type (2018-2023)
5.3.2 World Vaginal Antifungal Market Size by Type (2024-2029)
5.3.3 World Vaginal Antifungal Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaginal Antifungal Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Pharmacy
6.3 Market Segment by Application
6.3.1 World Vaginal Antifungal Market Size by Application (2018-2023)
6.3.2 World Vaginal Antifungal Market Size by Application (2024-2029)
6.3.3 World Vaginal Antifungal Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 ANI Pharmaceuticals
7.1.1 ANI Pharmaceuticals Details
7.1.2 ANI Pharmaceuticals Major Business
7.1.3 ANI Pharmaceuticals Vaginal Antifungal Product and Services
7.1.4 ANI Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 ANI Pharmaceuticals Recent Developments/Updates
7.1.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Lupin
7.2.1 Lupin Details
7.2.2 Lupin Major Business
7.2.3 Lupin Vaginal Antifungal Product and Services
7.2.4 Lupin Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lupin Recent Developments/Updates
7.2.6 Lupin Competitive Strengths & Weaknesses
7.3 Unique Pharmaceuticals
7.3.1 Unique Pharmaceuticals Details
7.3.2 Unique Pharmaceuticals Major Business
7.3.3 Unique Pharmaceuticals Vaginal Antifungal Product and Services
7.3.4 Unique Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Unique Pharmaceuticals Recent Developments/Updates
7.3.6 Unique Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Vaginal Antifungal Product and Services
7.4.4 Pfizer Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 SCYNEXIS
7.5.1 SCYNEXIS Details
7.5.2 SCYNEXIS Major Business
7.5.3 SCYNEXIS Vaginal Antifungal Product and Services
7.5.4 SCYNEXIS Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 SCYNEXIS Recent Developments/Updates
7.5.6 SCYNEXIS Competitive Strengths & Weaknesses
7.6 Bausch Health Companies
7.6.1 Bausch Health Companies Details
7.6.2 Bausch Health Companies Major Business
7.6.3 Bausch Health Companies Vaginal Antifungal Product and Services
7.6.4 Bausch Health Companies Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bausch Health Companies Recent Developments/Updates
7.6.6 Bausch Health Companies Competitive Strengths & Weaknesses
7.7 Hikma Pharmaceuticals
7.7.1 Hikma Pharmaceuticals Details
7.7.2 Hikma Pharmaceuticals Major Business
7.7.3 Hikma Pharmaceuticals Vaginal Antifungal Product and Services
7.7.4 Hikma Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Hikma Pharmaceuticals Recent Developments/Updates
7.7.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Pacgen Life Science Corporation
7.8.1 Pacgen Life Science Corporation Details
7.8.2 Pacgen Life Science Corporation Major Business
7.8.3 Pacgen Life Science Corporation Vaginal Antifungal Product and Services
7.8.4 Pacgen Life Science Corporation Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pacgen Life Science Corporation Recent Developments/Updates
7.8.6 Pacgen Life Science Corporation Competitive Strengths & Weaknesses
7.9 Astellas Pharma
7.9.1 Astellas Pharma Details
7.9.2 Astellas Pharma Major Business
7.9.3 Astellas Pharma Vaginal Antifungal Product and Services
7.9.4 Astellas Pharma Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Astellas Pharma Recent Developments/Updates
7.9.6 Astellas Pharma Competitive Strengths & Weaknesses
7.10 Mycovia Pharmaceuticals
7.10.1 Mycovia Pharmaceuticals Details
7.10.2 Mycovia Pharmaceuticals Major Business
7.10.3 Mycovia Pharmaceuticals Vaginal Antifungal Product and Services
7.10.4 Mycovia Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Mycovia Pharmaceuticals Recent Developments/Updates
7.10.6 Mycovia Pharmaceuticals Competitive Strengths & Weaknesses
7.11 PEPTONIC Medical
7.11.1 PEPTONIC Medical Details
7.11.2 PEPTONIC Medical Major Business
7.11.3 PEPTONIC Medical Vaginal Antifungal Product and Services
7.11.4 PEPTONIC Medical Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 PEPTONIC Medical Recent Developments/Updates
7.11.6 PEPTONIC Medical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vaginal Antifungal Industry Chain
8.2 Vaginal Antifungal Upstream Analysis
8.3 Vaginal Antifungal Midstream Analysis
8.4 Vaginal Antifungal Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
1.1 Vaginal Antifungal Introduction
1.2 World Vaginal Antifungal Market Size & Forecast (2018 & 2022 & 2029)
1.3 World Vaginal Antifungal Total Market by Region (by Headquarter Location)
1.3.1 World Vaginal Antifungal Market Size by Region (2018-2029), (by Headquarter Location)
1.3.2 United States Vaginal Antifungal Market Size (2018-2029)
1.3.3 China Vaginal Antifungal Market Size (2018-2029)
1.3.4 Europe Vaginal Antifungal Market Size (2018-2029)
1.3.5 Japan Vaginal Antifungal Market Size (2018-2029)
1.3.6 South Korea Vaginal Antifungal Market Size (2018-2029)
1.3.7 ASEAN Vaginal Antifungal Market Size (2018-2029)
1.3.8 India Vaginal Antifungal Market Size (2018-2029)
1.4 Market Drivers, Restraints and Trends
1.4.1 Vaginal Antifungal Market Drivers
1.4.2 Factors Affecting Demand
1.4.3 Vaginal Antifungal Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
1.5.1 Influence of COVID-19
1.5.2 Influence of Russia-Ukraine War
2 DEMAND SUMMARY
2.1 World Vaginal Antifungal Consumption Value (2018-2029)
2.2 World Vaginal Antifungal Consumption Value by Region
2.2.1 World Vaginal Antifungal Consumption Value by Region (2018-2023)
2.2.2 World Vaginal Antifungal Consumption Value Forecast by Region (2024-2029)
2.3 United States Vaginal Antifungal Consumption Value (2018-2029)
2.4 China Vaginal Antifungal Consumption Value (2018-2029)
2.5 Europe Vaginal Antifungal Consumption Value (2018-2029)
2.6 Japan Vaginal Antifungal Consumption Value (2018-2029)
2.7 South Korea Vaginal Antifungal Consumption Value (2018-2029)
2.8 ASEAN Vaginal Antifungal Consumption Value (2018-2029)
2.9 India Vaginal Antifungal Consumption Value (2018-2029)
3 WORLD VAGINAL ANTIFUNGAL COMPANIES COMPETITIVE ANALYSIS
3.1 World Vaginal Antifungal Revenue by Player (2018-2023)
3.2 Industry Rank and Concentration Rate (CR)
3.2.1 Global Vaginal Antifungal Industry Rank of Major Players
3.2.2 Global Concentration Ratios (CR4) for Vaginal Antifungal in 2022
3.2.3 Global Concentration Ratios (CR8) for Vaginal Antifungal in 2022
3.3 Vaginal Antifungal Company Evaluation Quadrant
3.4 Vaginal Antifungal Market: Overall Company Footprint Analysis
3.4.1 Vaginal Antifungal Market: Region Footprint
3.4.2 Vaginal Antifungal Market: Company Product Type Footprint
3.4.3 Vaginal Antifungal Market: Company Product Application Footprint
3.5 Competitive Environment
3.5.1 Historical Structure of the Industry
3.5.2 Barriers of Market Entry
3.5.3 Factors of Competition
3.6 Mergers, Acquisitions Activity
4 UNITED STATES VS CHINA VS REST OF THE WORLD (BY HEADQUARTER LOCATION)
4.1 United States VS China: Vaginal Antifungal Revenue Comparison (by Headquarter Location)
4.1.1 United States VS China: Vaginal Antifungal Market Size Comparison (2018 & 2022 & 2029) (by Headquarter Location)
4.1.2 United States VS China: Vaginal Antifungal Revenue Market Share Comparison (2018 & 2022 & 2029)
4.2 United States Based Companies VS China Based Companies: Vaginal Antifungal Consumption Value Comparison
4.2.1 United States VS China: Vaginal Antifungal Consumption Value Comparison (2018 & 2022 & 2029)
4.2.2 United States VS China: Vaginal Antifungal Consumption Value Market Share Comparison (2018 & 2022 & 2029)
4.3 United States Based Vaginal Antifungal Companies and Market Share, 2018-2023
4.3.1 United States Based Vaginal Antifungal Companies, Headquarters (States, Country)
4.3.2 United States Based Companies Vaginal Antifungal Revenue, (2018-2023)
4.4 China Based Companies Vaginal Antifungal Revenue and Market Share, 2018-2023
4.4.1 China Based Vaginal Antifungal Companies, Company Headquarters (Province, Country)
4.4.2 China Based Companies Vaginal Antifungal Revenue, (2018-2023)
4.5 Rest of World Based Vaginal Antifungal Companies and Market Share, 2018-2023
4.5.1 Rest of World Based Vaginal Antifungal Companies, Headquarters (States, Country)
4.5.2 Rest of World Based Companies Vaginal Antifungal Revenue, (2018-2023)
5 MARKET ANALYSIS BY TYPE
5.1 World Vaginal Antifungal Market Size Overview by Type: 2018 VS 2022 VS 2029
5.2 Segment Introduction by Type
5.2.1 Fluconazole
5.2.2 Clotrimazole
5.2.3 Ketoconazole
5.2.4 Others
5.3 Market Segment by Type
5.3.1 World Vaginal Antifungal Market Size by Type (2018-2023)
5.3.2 World Vaginal Antifungal Market Size by Type (2024-2029)
5.3.3 World Vaginal Antifungal Market Size Market Share by Type (2018-2029)
6 MARKET ANALYSIS BY APPLICATION
6.1 World Vaginal Antifungal Market Size Overview by Application: 2018 VS 2022 VS 2029
6.2 Segment Introduction by Application
6.2.1 Hospital
6.2.2 Clinic
6.2.3 Pharmacy
6.3 Market Segment by Application
6.3.1 World Vaginal Antifungal Market Size by Application (2018-2023)
6.3.2 World Vaginal Antifungal Market Size by Application (2024-2029)
6.3.3 World Vaginal Antifungal Market Size by Application (2018-2029)
7 COMPANY PROFILES
7.1 ANI Pharmaceuticals
7.1.1 ANI Pharmaceuticals Details
7.1.2 ANI Pharmaceuticals Major Business
7.1.3 ANI Pharmaceuticals Vaginal Antifungal Product and Services
7.1.4 ANI Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.1.5 ANI Pharmaceuticals Recent Developments/Updates
7.1.6 ANI Pharmaceuticals Competitive Strengths & Weaknesses
7.2 Lupin
7.2.1 Lupin Details
7.2.2 Lupin Major Business
7.2.3 Lupin Vaginal Antifungal Product and Services
7.2.4 Lupin Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.2.5 Lupin Recent Developments/Updates
7.2.6 Lupin Competitive Strengths & Weaknesses
7.3 Unique Pharmaceuticals
7.3.1 Unique Pharmaceuticals Details
7.3.2 Unique Pharmaceuticals Major Business
7.3.3 Unique Pharmaceuticals Vaginal Antifungal Product and Services
7.3.4 Unique Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.3.5 Unique Pharmaceuticals Recent Developments/Updates
7.3.6 Unique Pharmaceuticals Competitive Strengths & Weaknesses
7.4 Pfizer
7.4.1 Pfizer Details
7.4.2 Pfizer Major Business
7.4.3 Pfizer Vaginal Antifungal Product and Services
7.4.4 Pfizer Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.4.5 Pfizer Recent Developments/Updates
7.4.6 Pfizer Competitive Strengths & Weaknesses
7.5 SCYNEXIS
7.5.1 SCYNEXIS Details
7.5.2 SCYNEXIS Major Business
7.5.3 SCYNEXIS Vaginal Antifungal Product and Services
7.5.4 SCYNEXIS Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.5.5 SCYNEXIS Recent Developments/Updates
7.5.6 SCYNEXIS Competitive Strengths & Weaknesses
7.6 Bausch Health Companies
7.6.1 Bausch Health Companies Details
7.6.2 Bausch Health Companies Major Business
7.6.3 Bausch Health Companies Vaginal Antifungal Product and Services
7.6.4 Bausch Health Companies Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.6.5 Bausch Health Companies Recent Developments/Updates
7.6.6 Bausch Health Companies Competitive Strengths & Weaknesses
7.7 Hikma Pharmaceuticals
7.7.1 Hikma Pharmaceuticals Details
7.7.2 Hikma Pharmaceuticals Major Business
7.7.3 Hikma Pharmaceuticals Vaginal Antifungal Product and Services
7.7.4 Hikma Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.7.5 Hikma Pharmaceuticals Recent Developments/Updates
7.7.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.8 Pacgen Life Science Corporation
7.8.1 Pacgen Life Science Corporation Details
7.8.2 Pacgen Life Science Corporation Major Business
7.8.3 Pacgen Life Science Corporation Vaginal Antifungal Product and Services
7.8.4 Pacgen Life Science Corporation Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.8.5 Pacgen Life Science Corporation Recent Developments/Updates
7.8.6 Pacgen Life Science Corporation Competitive Strengths & Weaknesses
7.9 Astellas Pharma
7.9.1 Astellas Pharma Details
7.9.2 Astellas Pharma Major Business
7.9.3 Astellas Pharma Vaginal Antifungal Product and Services
7.9.4 Astellas Pharma Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.9.5 Astellas Pharma Recent Developments/Updates
7.9.6 Astellas Pharma Competitive Strengths & Weaknesses
7.10 Mycovia Pharmaceuticals
7.10.1 Mycovia Pharmaceuticals Details
7.10.2 Mycovia Pharmaceuticals Major Business
7.10.3 Mycovia Pharmaceuticals Vaginal Antifungal Product and Services
7.10.4 Mycovia Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.10.5 Mycovia Pharmaceuticals Recent Developments/Updates
7.10.6 Mycovia Pharmaceuticals Competitive Strengths & Weaknesses
7.11 PEPTONIC Medical
7.11.1 PEPTONIC Medical Details
7.11.2 PEPTONIC Medical Major Business
7.11.3 PEPTONIC Medical Vaginal Antifungal Product and Services
7.11.4 PEPTONIC Medical Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023)
7.11.5 PEPTONIC Medical Recent Developments/Updates
7.11.6 PEPTONIC Medical Competitive Strengths & Weaknesses
8 INDUSTRY CHAIN ANALYSIS
8.1 Vaginal Antifungal Industry Chain
8.2 Vaginal Antifungal Upstream Analysis
8.3 Vaginal Antifungal Midstream Analysis
8.4 Vaginal Antifungal Downstream Analysis
9 RESEARCH FINDINGS AND CONCLUSION
10 APPENDIX
10.1 Methodology
10.2 Research Process and Data Source
10.3 Disclaimer
LIST OF TABLES
Table 1. World Vaginal Antifungal Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Vaginal Antifungal Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Vaginal Antifungal Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Vaginal Antifungal Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Vaginal Antifungal Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Vaginal Antifungal Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Vaginal Antifungal Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Vaginal Antifungal Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Vaginal Antifungal Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Vaginal Antifungal Players in 2022
Table 12. World Vaginal Antifungal Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Vaginal Antifungal Company Evaluation Quadrant
Table 14. Head Office of Key Vaginal Antifungal Player
Table 15. Vaginal Antifungal Market: Company Product Type Footprint
Table 16. Vaginal Antifungal Market: Company Product Application Footprint
Table 17. Vaginal Antifungal Mergers & Acquisitions Activity
Table 18. United States VS China Vaginal Antifungal Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Vaginal Antifungal Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Vaginal Antifungal Companies, Headquarters (States, Country)
Table 21. United States Based Companies Vaginal Antifungal Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Vaginal Antifungal Revenue Market Share (2018-2023)
Table 23. China Based Vaginal Antifungal Companies, Headquarters (Province, Country)
Table 24. China Based Companies Vaginal Antifungal Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Vaginal Antifungal Revenue Market Share (2018-2023)
Table 26. Rest of World Based Vaginal Antifungal Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Vaginal Antifungal Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Vaginal Antifungal Revenue Market Share (2018-2023)
Table 29. World Vaginal Antifungal Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Vaginal Antifungal Market Size by Type (2018-2023) & (USD Million)
Table 31. World Vaginal Antifungal Market Size by Type (2024-2029) & (USD Million)
Table 32. World Vaginal Antifungal Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Vaginal Antifungal Market Size by Application (2018-2023) & (USD Million)
Table 34. World Vaginal Antifungal Market Size by Application (2024-2029) & (USD Million)
Table 35. ANI Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. ANI Pharmaceuticals Major Business
Table 37. ANI Pharmaceuticals Vaginal Antifungal Product and Services
Table 38. ANI Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ANI Pharmaceuticals Recent Developments/Updates
Table 40. ANI Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. Lupin Basic Information, Area Served and Competitors
Table 42. Lupin Major Business
Table 43. Lupin Vaginal Antifungal Product and Services
Table 44. Lupin Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lupin Recent Developments/Updates
Table 46. Lupin Competitive Strengths & Weaknesses
Table 47. Unique Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Unique Pharmaceuticals Major Business
Table 49. Unique Pharmaceuticals Vaginal Antifungal Product and Services
Table 50. Unique Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Unique Pharmaceuticals Recent Developments/Updates
Table 52. Unique Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Pfizer Basic Information, Area Served and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Vaginal Antifungal Product and Services
Table 56. Pfizer Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Pfizer Recent Developments/Updates
Table 58. Pfizer Competitive Strengths & Weaknesses
Table 59. SCYNEXIS Basic Information, Area Served and Competitors
Table 60. SCYNEXIS Major Business
Table 61. SCYNEXIS Vaginal Antifungal Product and Services
Table 62. SCYNEXIS Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. SCYNEXIS Recent Developments/Updates
Table 64. SCYNEXIS Competitive Strengths & Weaknesses
Table 65. Bausch Health Companies Basic Information, Area Served and Competitors
Table 66. Bausch Health Companies Major Business
Table 67. Bausch Health Companies Vaginal Antifungal Product and Services
Table 68. Bausch Health Companies Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bausch Health Companies Recent Developments/Updates
Table 70. Bausch Health Companies Competitive Strengths & Weaknesses
Table 71. Hikma Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Hikma Pharmaceuticals Major Business
Table 73. Hikma Pharmaceuticals Vaginal Antifungal Product and Services
Table 74. Hikma Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Hikma Pharmaceuticals Recent Developments/Updates
Table 76. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Pacgen Life Science Corporation Basic Information, Area Served and Competitors
Table 78. Pacgen Life Science Corporation Major Business
Table 79. Pacgen Life Science Corporation Vaginal Antifungal Product and Services
Table 80. Pacgen Life Science Corporation Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pacgen Life Science Corporation Recent Developments/Updates
Table 82. Pacgen Life Science Corporation Competitive Strengths & Weaknesses
Table 83. Astellas Pharma Basic Information, Area Served and Competitors
Table 84. Astellas Pharma Major Business
Table 85. Astellas Pharma Vaginal Antifungal Product and Services
Table 86. Astellas Pharma Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Astellas Pharma Recent Developments/Updates
Table 88. Astellas Pharma Competitive Strengths & Weaknesses
Table 89. Mycovia Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Mycovia Pharmaceuticals Major Business
Table 91. Mycovia Pharmaceuticals Vaginal Antifungal Product and Services
Table 92. Mycovia Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Mycovia Pharmaceuticals Recent Developments/Updates
Table 94. PEPTONIC Medical Basic Information, Area Served and Competitors
Table 95. PEPTONIC Medical Major Business
Table 96. PEPTONIC Medical Vaginal Antifungal Product and Services
Table 97. PEPTONIC Medical Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Vaginal Antifungal Upstream (Raw Materials)
Table 99. Vaginal Antifungal Typical Customers
Table 1. World Vaginal Antifungal Revenue by Region (2018, 2022 and 2029) & (USD Million), (by Headquarter Location)
Table 2. World Vaginal Antifungal Revenue by Region (2018-2023) & (USD Million), (by Headquarter Location)
Table 3. World Vaginal Antifungal Revenue by Region (2024-2029) & (USD Million), (by Headquarter Location)
Table 4. World Vaginal Antifungal Revenue Market Share by Region (2018-2023), (by Headquarter Location)
Table 5. World Vaginal Antifungal Revenue Market Share by Region (2024-2029), (by Headquarter Location)
Table 6. Major Market Trends
Table 7. World Vaginal Antifungal Consumption Value Growth Rate Forecast by Region (2018 & 2022 & 2029) & (USD Million)
Table 8. World Vaginal Antifungal Consumption Value by Region (2018-2023) & (USD Million)
Table 9. World Vaginal Antifungal Consumption Value Forecast by Region (2024-2029) & (USD Million)
Table 10. World Vaginal Antifungal Revenue by Player (2018-2023) & (USD Million)
Table 11. Revenue Market Share of Key Vaginal Antifungal Players in 2022
Table 12. World Vaginal Antifungal Industry Rank of Major Player, Based on Revenue in 2022
Table 13. Global Vaginal Antifungal Company Evaluation Quadrant
Table 14. Head Office of Key Vaginal Antifungal Player
Table 15. Vaginal Antifungal Market: Company Product Type Footprint
Table 16. Vaginal Antifungal Market: Company Product Application Footprint
Table 17. Vaginal Antifungal Mergers & Acquisitions Activity
Table 18. United States VS China Vaginal Antifungal Market Size Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 19. United States VS China Vaginal Antifungal Consumption Value Comparison, (2018 & 2022 & 2029) & (USD Million)
Table 20. United States Based Vaginal Antifungal Companies, Headquarters (States, Country)
Table 21. United States Based Companies Vaginal Antifungal Revenue, (2018-2023) & (USD Million)
Table 22. United States Based Companies Vaginal Antifungal Revenue Market Share (2018-2023)
Table 23. China Based Vaginal Antifungal Companies, Headquarters (Province, Country)
Table 24. China Based Companies Vaginal Antifungal Revenue, (2018-2023) & (USD Million)
Table 25. China Based Companies Vaginal Antifungal Revenue Market Share (2018-2023)
Table 26. Rest of World Based Vaginal Antifungal Companies, Headquarters (States, Country)
Table 27. Rest of World Based Companies Vaginal Antifungal Revenue, (2018-2023) & (USD Million)
Table 28. Rest of World Based Companies Vaginal Antifungal Revenue Market Share (2018-2023)
Table 29. World Vaginal Antifungal Market Size by Type, (USD Million), 2018 & 2022 & 2029
Table 30. World Vaginal Antifungal Market Size by Type (2018-2023) & (USD Million)
Table 31. World Vaginal Antifungal Market Size by Type (2024-2029) & (USD Million)
Table 32. World Vaginal Antifungal Market Size by Application, (USD Million), 2018 & 2022 & 2029
Table 33. World Vaginal Antifungal Market Size by Application (2018-2023) & (USD Million)
Table 34. World Vaginal Antifungal Market Size by Application (2024-2029) & (USD Million)
Table 35. ANI Pharmaceuticals Basic Information, Area Served and Competitors
Table 36. ANI Pharmaceuticals Major Business
Table 37. ANI Pharmaceuticals Vaginal Antifungal Product and Services
Table 38. ANI Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 39. ANI Pharmaceuticals Recent Developments/Updates
Table 40. ANI Pharmaceuticals Competitive Strengths & Weaknesses
Table 41. Lupin Basic Information, Area Served and Competitors
Table 42. Lupin Major Business
Table 43. Lupin Vaginal Antifungal Product and Services
Table 44. Lupin Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 45. Lupin Recent Developments/Updates
Table 46. Lupin Competitive Strengths & Weaknesses
Table 47. Unique Pharmaceuticals Basic Information, Area Served and Competitors
Table 48. Unique Pharmaceuticals Major Business
Table 49. Unique Pharmaceuticals Vaginal Antifungal Product and Services
Table 50. Unique Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 51. Unique Pharmaceuticals Recent Developments/Updates
Table 52. Unique Pharmaceuticals Competitive Strengths & Weaknesses
Table 53. Pfizer Basic Information, Area Served and Competitors
Table 54. Pfizer Major Business
Table 55. Pfizer Vaginal Antifungal Product and Services
Table 56. Pfizer Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 57. Pfizer Recent Developments/Updates
Table 58. Pfizer Competitive Strengths & Weaknesses
Table 59. SCYNEXIS Basic Information, Area Served and Competitors
Table 60. SCYNEXIS Major Business
Table 61. SCYNEXIS Vaginal Antifungal Product and Services
Table 62. SCYNEXIS Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 63. SCYNEXIS Recent Developments/Updates
Table 64. SCYNEXIS Competitive Strengths & Weaknesses
Table 65. Bausch Health Companies Basic Information, Area Served and Competitors
Table 66. Bausch Health Companies Major Business
Table 67. Bausch Health Companies Vaginal Antifungal Product and Services
Table 68. Bausch Health Companies Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 69. Bausch Health Companies Recent Developments/Updates
Table 70. Bausch Health Companies Competitive Strengths & Weaknesses
Table 71. Hikma Pharmaceuticals Basic Information, Area Served and Competitors
Table 72. Hikma Pharmaceuticals Major Business
Table 73. Hikma Pharmaceuticals Vaginal Antifungal Product and Services
Table 74. Hikma Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 75. Hikma Pharmaceuticals Recent Developments/Updates
Table 76. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 77. Pacgen Life Science Corporation Basic Information, Area Served and Competitors
Table 78. Pacgen Life Science Corporation Major Business
Table 79. Pacgen Life Science Corporation Vaginal Antifungal Product and Services
Table 80. Pacgen Life Science Corporation Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 81. Pacgen Life Science Corporation Recent Developments/Updates
Table 82. Pacgen Life Science Corporation Competitive Strengths & Weaknesses
Table 83. Astellas Pharma Basic Information, Area Served and Competitors
Table 84. Astellas Pharma Major Business
Table 85. Astellas Pharma Vaginal Antifungal Product and Services
Table 86. Astellas Pharma Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 87. Astellas Pharma Recent Developments/Updates
Table 88. Astellas Pharma Competitive Strengths & Weaknesses
Table 89. Mycovia Pharmaceuticals Basic Information, Area Served and Competitors
Table 90. Mycovia Pharmaceuticals Major Business
Table 91. Mycovia Pharmaceuticals Vaginal Antifungal Product and Services
Table 92. Mycovia Pharmaceuticals Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 93. Mycovia Pharmaceuticals Recent Developments/Updates
Table 94. PEPTONIC Medical Basic Information, Area Served and Competitors
Table 95. PEPTONIC Medical Major Business
Table 96. PEPTONIC Medical Vaginal Antifungal Product and Services
Table 97. PEPTONIC Medical Vaginal Antifungal Revenue, Gross Margin and Market Share (2018-2023) & (USD Million)
Table 98. Global Key Players of Vaginal Antifungal Upstream (Raw Materials)
Table 99. Vaginal Antifungal Typical Customers
LIST OF FIGURES
Figure 1. Vaginal Antifungal Picture
Figure 2. World Vaginal Antifungal Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vaginal Antifungal Total Market Size (2018-2029) & (USD Million)
Figure 4. World Vaginal Antifungal Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Vaginal Antifungal Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 13. Vaginal Antifungal Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 16. World Vaginal Antifungal Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 18. China Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 23. India Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Vaginal Antifungal by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Vaginal Antifungal Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Vaginal Antifungal Markets in 2022
Figure 27. United States VS China: Vaginal Antifungal Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vaginal Antifungal Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Vaginal Antifungal Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Vaginal Antifungal Market Size Market Share by Type in 2022
Figure 31. Fluconazole
Figure 32. Clotrimazole
Figure 33. Ketoconazole
Figure 34. Others
Figure 35. World Vaginal Antifungal Market Size Market Share by Type (2018-2029)
Figure 36. World Vaginal Antifungal Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Vaginal Antifungal Market Size Market Share by Application in 2022
Figure 38. Hospital
Figure 39. Clinic
Figure 40. Pharmacy
Figure 41. Vaginal Antifungal Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
Figure 1. Vaginal Antifungal Picture
Figure 2. World Vaginal Antifungal Total Market Size: 2018 & 2022 & 2029, (USD Million)
Figure 3. World Vaginal Antifungal Total Market Size (2018-2029) & (USD Million)
Figure 4. World Vaginal Antifungal Revenue Market Share by Region (2018, 2022 and 2029) & (USD Million) , (by Headquarter Location)
Figure 5. World Vaginal Antifungal Revenue Market Share by Region (2018-2029), (by Headquarter Location)
Figure 6. United States Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 7. China Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 8. Europe Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 9. Japan Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 10. South Korea Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 11. ASEAN Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 12. India Based Company Vaginal Antifungal Revenue (2018-2029) & (USD Million)
Figure 13. Vaginal Antifungal Market Drivers
Figure 14. Factors Affecting Demand
Figure 15. World Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 16. World Vaginal Antifungal Consumption Value Market Share by Region (2018-2029)
Figure 17. United States Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 18. China Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 20. Japan Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 21. South Korea Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 22. ASEAN Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 23. India Vaginal Antifungal Consumption Value (2018-2029) & (USD Million)
Figure 24. Producer Shipments of Vaginal Antifungal by Player Revenue ($MM) and Market Share (%): 2022
Figure 25. Global Four-firm Concentration Ratios (CR4) for Vaginal Antifungal Markets in 2022
Figure 26. Global Four-firm Concentration Ratios (CR8) for Vaginal Antifungal Markets in 2022
Figure 27. United States VS China: Vaginal Antifungal Revenue Market Share Comparison (2018 & 2022 & 2029)
Figure 28. United States VS China: Vaginal Antifungal Consumption Value Market Share Comparison (2018 & 2022 & 2029)
Figure 29. World Vaginal Antifungal Market Size by Type, (USD Million), 2018 & 2022 & 2029
Figure 30. World Vaginal Antifungal Market Size Market Share by Type in 2022
Figure 31. Fluconazole
Figure 32. Clotrimazole
Figure 33. Ketoconazole
Figure 34. Others
Figure 35. World Vaginal Antifungal Market Size Market Share by Type (2018-2029)
Figure 36. World Vaginal Antifungal Market Size by Application, (USD Million), 2018 & 2022 & 2029
Figure 37. World Vaginal Antifungal Market Size Market Share by Application in 2022
Figure 38. Hospital
Figure 39. Clinic
Figure 40. Pharmacy
Figure 41. Vaginal Antifungal Industrial Chain
Figure 42. Methodology
Figure 43. Research Process and Data Source
